PhaseBio Pharmaceuticals, Inc. (PHAS)

Cash & Short-Term Investments

$7.80M

Quarterly · Period ending: · USD

PHAS logo

PHAS Cash & Short-Term Investments

Latest reported$7.80M
PHAS Quarterly Cash & Short-Term Investments ($13.41M → $7.80M)
High-resolution chart · PNG

PHAS cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
7,804,000
18,688,000
41,800,000
56,357,000
64,456,000
76,963,000
28,122,000
39,353,000
53,025,000
59,441,000
74,025,000
81,771,000
90,342,000
51,894,000
61,031,000
24,341,000
28,446,000
13,406,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.